Daniel J. DeAngelo
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research
Most-Cited Works
- → A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome(2003)1,690 cited
- → Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia(2017)1,447 cited
- → MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia(2006)1,402 cited
- → Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia(2016)1,340 cited
- → A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias(2013)1,111 cited
- → Differentiation and reversal of malignant changes in colon cancer through PPARγ(1998)970 cited
- →